Notable portfolio companies include Anji Pharmaceuticals, Arthrosi Therapeutics, Blue Oak Pharmaceuticals, and SQZ Biotechnologies. Key partners or decision-makers are not specified, but the firm's investment philosophy emphasizes substantial support for early-stage biotech ventures. Viva Ventures Biotech Fund offers unique value-add services tailored to the specific needs of biotech startups, ensuring they have the resources and guidance necessary for successful development and growth.
Classification
Also Known As
Viva Ventures Biotech L.P.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
Recorded Recipients10
Repeat Participations3
Operating Recipients7
Top Investment Stages
Series A7 (53.8%)
Seed3 (23.1%)
Series C3 (23.1%)
Acquired Recipients1
Closed Recipients1
Public Recipients1
Viva Ventures Biotech Fund
Viva Ventures Biotech Fund is a large-scale investment firm focusing on biotech startups, supporting companies from the idea stage to inception. The firm typically invests in various stages, including Seed, Series A, and Series C rounds, providing significant financial backing to foster innovation in the biotech sector.
